Cluster headache: crosspoint between otologists and neurologists—treatment of the sphenopalatine ganglion and systematic review
- 1 Downloads
Among cephalgias, cluster headache (CH) is the rarest and the most disabling, explaining the appellation of “suicide headache.” Up to 20% of chronic CH reveals to be resistant to pharmacological treatments, in which case interventional procedures should be considered. Many reports evaluated invasive approaches and a wide strand of research is dedicated to the sphenopalatine ganglion. Our paper will now be focused on providing an overview on modern applications on the sphenopalatine ganglion (SPG), their outcomes, and their feasibility in terms of risks and benefits. The group reviewed the international literature systematically for procedures targeting the sphenopalatine ganglion and its branches for episodic and chronic CH, including block, stimulation, radiofrequency, stereotactic radiosurgery, and vidian neurectomy. Seventeen articles fixed our inclusion criteria. Comparing the outcomes that have been analyzed, it is possible to notice how the most successful procedure for the treatment of refractory chronic and episodic CH is the SPG block, which reaches respectively 76.5% and 87% of efficacy. Radiofrequency has a wide range of outcomes, from 33 to 70.3% in CCH. Stimulation of SPG only achieved up to 55% of outcomes in significant reduction in attack frequency in CCH and 71% in ECH. Radiosurgery and vidian neurectomy on SPG have also been analyzed. Generally, ECH patients show better response to standard medical therapies; nevertheless, even this more manageable condition may sometimes benefit from interventional therapies mostly reserved for CCH. First results seem promising and considering the low frequency of side effects or complications, we should think of expanding the indications of the procedures also to those conditions. Outcomes certainly suggest that further studies are necessary in order to understand which method is the most effective and with less side effects. Placebo-controlled studies would be pivotal, and tight collaboration between neurologists and otorhinolaryngologists should also be central in order to give correct indications, which allow us to expect procedures on the SPG to be an effective and mostly safe method to control either refractory ECH or CCH.
KeywordsCluster headache Sphenopalatine ganglion Endoscopic transnasal approach Refractory headache Cephalgia
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any study with human subjects performed by any of the authors.
- 3.Fanciullacci M, Alessandri M (2018) Le cefalee primarie nella pratica clinica. Google LibriGoogle Scholar
- 4.Farri A, Enrico A, Farri F (2012) Headaches of otolaryngological interest: current status while awaiting revision of classification. Practical considerations and expectations. Acta Otorhinolaryngol Ital 32(2):77–86Google Scholar
- 11.Gaul C, Diener HC, Silver N, Magis D, Reuter U, Andersson A, Liebler EJ, Straube A, on behalf of the PREVA Study Group (2016) Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): a randomised controlled study. Cephalalgia 36(6):534–546CrossRefGoogle Scholar
- 14.Ji T, Yang Z, Liu Q, Liao J, Yin F, Chen Y, Zou L, Li B, Gao Y, Shu X, Huang S, Gao F, Liang J, Lin SF, Peng J, Song S, Wang J, Che C, Sun W, Tian M, Yang L, Hua Y, Hao Y, Cai L, Li L, Jiang Y (2019) Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial. Trials 20(1):44CrossRefGoogle Scholar
- 20.Vyas DB, Ho AL, Dadey DY, Pendharkar AV, Sussman ES, Cowan R, Halpern CH (2018) Deep brain stimulation for chronic cluster headache: a review. Neuromodulation Technol Neural InterfaceGoogle Scholar
- 27.Carroll I, Hah J, Nicholson D, Coleman S (2011) Local anesthetics and other interventional approaches. In: Neuropatic pain: cause, management and understanding, pp 267–272Google Scholar
- 28.Zanella S et al (2018) Transnasal sphenopalatine ganglion blockade for acute facial pain: a prospective randomized case-control study. Eur Rev Med Pharmacol Sci 22(1):210–216Google Scholar
- 36.Devoghel JCC (1981) Cluster headache and sphenopalatine block. Acta Anaesthesiol Belg 32(1):101–107Google Scholar
- 37.Filippini-De Moor GPG et al (1999) Retrospective analysis of radiofrequency lesions of the sphenopalatine ganglion in the treatment of 19 cluster headache patients. Pain Clin 11(4):285–291Google Scholar
- 40.Salgado-Lopez L et al (2018) Efficacy of sphenopalatine ganglion radiofrequency in refractory chronic cluster headache. World NeurosurgGoogle Scholar
- 42.Kano H, Kondziolka D, Mathieu D, Stafford SL, Flannery TJ, Niranjan A, Pollock BE, Kaufmann AM, Flickinger JC, Lunsford LD (2011) Stereotactic radiosurgery for intractable cluster headache: an initial report from the North American Gamma Knife Consortium. J Neurosurg 114(6):1736–1743CrossRefGoogle Scholar
- 47.Barloese M et al (2016) Pathway registry 12 month interim results - long-term therapeutic effectiveness of sphenopalatine ganglion (SPG) stimulation for cluster headache (CH). CEPHALALGIA 36(1):1396–1397Google Scholar
- 48.Liu S-C, Kao M-C, Huang Y-C, Su W-F (2018) Vidian neurectomy for management of chronic cluster headache. NeurosurgeryGoogle Scholar